Accounts Payable, Accrued Expenses and Other Current Liabilities, and Other Long-Term Liabilities (Tables)

12 Months Ended

Jul. 31, 2024

Accounts Payable, Accrued Expenses and Other Current Liabilities, and Other Long-Term Liabilities [Abstract]

Schedule of Accounts Payable, Accrued Expenses and Other Current Liabilities

Accounts payable, accrued expenses and other current liabilities consisted of the following:

	As of July 31,
	2024		2023
Accounts payable, accrued expenses and other current liabilities:
Accrued litigation fee, current (a)	$	750,000	$	-
Investment securities payable	$	69,621		-
Accrued payroll expenses		-		212,953
Others		137,436		80,187
	$	957,057	$	293,140
Other long-term liabilities:
Accrued litigation fee, noncurrent (a)	$	250,000	$	-

(a) On September 24, 2024, the Company and Boustead Securities, LLC (“Boustead”) entered into a settlement agreement, pursuant to which the Company would compensate Boustead in the amount of $1,000,000 (Note 14). The compensation is payable in three instalments, with first instalment of $250,000 payable with execution of settlement agreement, the second instalment of $500,000 payable before March 1, 2025, and the final instalment of $250,000 payable before December 31, 2025. Accordingly, the Company recorded accrued litigation fees of $750,000 as current liabilities, and the remaining $250,000 as noncurrent liabilities.